You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 319 Phase II trial of immunotherapy in primary glioblastoma: antigens from self-renewing autologous tumor cells presented by autologous dendritic cell vaccine

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials in progress
319 Phase II trial of immunotherapy in primary glioblastoma: antigens from self-renewing autologous tumor cells presented by autologous dendritic cell vaccine

 

Online download statistics by month:

Online download statistics by month: November 2020 to November 2024

AbstractFullPdf
Nov 202012709
Dec 202044029
Jan 20212002
Feb 20213004
Mar 20215407
Apr 20212405
May 20211108
Jun 2021005
Jul 2021004
Aug 2021007
Sep 2021004
Oct 202130019
Nov 202136021
Dec 20211601
Jan 20221401
Feb 20222203
Mar 20222201
Apr 20221602
May 20223007
Jun 20222007
Jul 20221800
Aug 20222202
Sep 20221006
Oct 20221003
Nov 20221202
Dec 20223603
Jan 20231201
Feb 20231600
Mar 20231807
Apr 202312012
May 20232001
Jun 20231600
Jul 20231406
Aug 20231203
Sep 2023201
Oct 20231604
Nov 20231001
Dec 20233601
Jan 20241801
Feb 20241601
Mar 20241804
Apr 20241003
May 20241401
Jun 20241600
Jul 20241003
Aug 2024802
Sep 20242204
Oct 20241406
Nov 20241004
Total9640228